ABSTRACT
OBJETIVOS: Calculamos la asociación entre el precio de diversas categorías de alimentos saludables y menos saludables y la glucemia en adultos estadounidenses con diabetes de tipo 2. MÉTODOS: Vinculamos la información de salud contenida en la Encuesta Nacional de Salud y Nutrición 1999-2006 y el precio de los alimentos a partir de la base trimestral de datos de precios de los alimentos. Aplicamos una regresión de los valores de glucemia con respecto al precio de los alimentos en el trimestre anterior, con control de la región del mercado y otras covariables. Examinamos asimismo si la asociación entre el precio de los alimentos y la glucemia variaba entre distintos grupos de ingresos. RESULTADOS: Tanto el precio de las frutas y verduras como el precio de los productos lácteos magros se asocian a la glucemia en las personas con diabetes de tipo 2. En concreto, un precio mayor de las frutas y verduras y de los productos lácteos se asocia a valores más altos de glu-cohemoglobina y de glucemia en ayunas tres meses después. La asociación entre el precio de los alimentos y la glucemia es mayor en las personas de ingresos bajos que en las de ingresos elevados, en la dirección esperada. CONCLUSIONES: Un precio mayor de los alimentos saludables se asocia a cifras más elevadas de glucemia en las personas con diabetes de tipo 2. Esta asociación fue especialmente pronunciada en las personas con diabetes de tipo 2 con ingresos bajos.
OBJECTIVES: We estimated the association between the price of healthy and less-healthy food groups and blood sugar among US adults with type 2 diabetes. METHODS: We linked 1999-2006 National Health and Nutrition Examination Survey health information to food prices contained in the Quarterly Food-at-Home Price Database. We regressed blood sugar levels on food prices from the previous calendar quarter, controlling for market region and a range of other covariates. We also examined whether the association between food prices and blood sugar varies among different income groups. RESULTS: The prices of produce and low-fat dairy foods were associated with blood sugar levels of people with type 2 diabetes. Specifically, higher prices for produce and low-fat dairy foods were associated with higher levels of glycated hemoglobin and fasting plasma glucose 3 months later. Food prices had a greater association with blood sugar for low-income people than for higherincome people, and in the expected direction. CONCLUSIONS: Higher prices of healthy foods were associated with increased blood sugar among people with type 2 diabetes. The association was especially pronounced among low-income people with type 2 diabetes.
Subject(s)
Humans , Male , Female , Pregnancy , Infant, Newborn , Adult , Birth Injuries/diagnosis , Dystocia , Trachea/injuries , Tracheal Diseases/etiology , Birth Injuries/therapy , Bronchoscopes , Rupture , Tracheal Diseases/therapyABSTRACT
La traqueobroncopatía osteocondroplástica (TO) (o traqueopatía osteocondroplástica otraqueopatía osteoplástica)1 es una entidad rara de etiopatogenia desconocida caracterizada por múltiples nódulos de cartílago o hueso originados en el tejido cartilaginoso de la vía aérea, que se proyectan dentro de la luz traqueobronquial. Generalmente decurso crónico y benigno, es casi siempre un hallazgo; cuando presenta síntomas estos son inespecíficos y se deben al estrechamiento de la vía aérea, al engrosamiento de la pared traqueobronquial, o a alguna complicación. Al ser poco reconocida favorece los errores diagnósticos. Reportamos un caso sintomático de TO, confundida con asma, que además presentaba rinosinusitis crónica e infecciones recurrentes de la vía aérea alta y baja. Además de presentar este caso con gran afectación y progresión hasta bronquios distales, mostramos otros 2 presuntos casos sin confirmación endoscópica.
The tracheobronchopathia osteochondroplastica (TO) is a rare disease of unknown pathogenesis. It is characterized by multiple osteocartilaginous nodules protrudinginto the tracheobronchial airway lumen. Generally it is an incidental finding because its evolution is chronic and benign; when symptoms are present, they are non specific and result from the obstruction of the airway, the thickening of the tracheobronchial wall or some complication. Since it is an uncommon condition the diagnostic errors arefrequent. We report a symptomatic TO case, that was misdiagnosed as asthma, and in addition the patient had chronic sinusitis and recurrent upper and lower respiratory tract infections. This case had progressive invasion of distal bronchi. We also report two other suspected cases without endoscopic confirmation.
Subject(s)
Humans , Female , Middle Aged , Asthma/therapy , Bronchial Diseases/diagnosis , Tracheal Diseases/diagnosis , Osteochondrodysplasias/diagnosis , Bronchoscopy , Bronchial Diseases/etiology , Bronchial Diseases/therapy , Tracheal Diseases/etiology , Tracheal Diseases/therapy , Osteochondrodysplasias/etiology , Tomography, X-Ray ComputedABSTRACT
As fístulas da árvore traqueobrônquica, sejam elas broncopleurais ou traqueoesofágicas, apresentam etiologia multifatorial, com incidência variável na literatura. Em geral, apresentam alta morbidade e mortalidade, com indicação formal de correção cirúrgica. Entretanto, a condição clínica dos pacientes muitas vezes não permite uma reintervenção cirúrgica de grande porte. Além disso, as tentativas de fechamento endoscópico raramente têm sucesso, principalmente em fístulas de grande diâmetro. Relatamos os casos de três pacientes submetidos ao fechamento endoscópico de fístulas, sendo duas maiores que 10 mm, com a aplicação de dispositivos oclusores utilizados na cardiologia intervencionista, de forma minimamente invasiva e com resultados iniciais positivos. Esses dados sinalizam que essa pode ser uma técnica promissora na resolução de fístulas da árvore traqueobrônquica.
Fistulas in the tracheobronchial tree (bronchopleural and tracheoesophageal fistulas) have a multifactorial etiology and present a variable incidence in the literature. In general, the related morbidity and mortality are high. Once such a fistula has been diagnosed, surgical closure is formally indicated. However, the clinical status of affected patients is usually unfavorable, which precludes the use of additional, extensive surgical interventions. In addition, attempts at endoscopic closure of these fistulas have seldom been successful, especially when the fistula is large in diameter. We report the cases of three patients submitted to endoscopic closure of fistulas, two of which were larger than 10 mm in diameter, by means of the insertion of atrial septal defect occluders. The procedure was minimally invasive, and the initial results were positive. The results indicate that this is a promising technique for the resolution of tracheobronchial tree fistulas.
Subject(s)
Aged , Humans , Male , Middle Aged , Bronchoscopy , Bronchial Fistula/therapy , Respiratory Tract Fistula/therapy , Septal Occluder Device , Tracheal Diseases/therapyABSTRACT
Background: Tracheobronchomalacia is characterized by a deficiency in the cartilaginous support of the trachea and bronchi and hypotony in the myoelastic elements, that lead to different levels of airway obstruction. Aim: To report our experience in the treatment of traqueobronchomalacia. Material and methods: Retrospective review of 24 patients with tracheomalacia of different levels (3 tracheobronchomalacia, 3 laryngotracheomalacia) and 8 patients with bronchomalacia. Results: The age at diagnosis ranged from 9 days to 9 years. Clinical presentation was recurrent wheezing in 19 patients, stridor in 6 and atelectasis in 4. The associated factors were neurological impairment in 8, congenital heart disease in 10 and prolonged mechanical ventilation in 4. The diagnosis was done by flexible bronchoscopy in all patients, using sedation and allowing spontaneous breathing. At the moment of diagnosis, treatment consisted in oxygen supply in 14 patients, physiotherapy in 21, õ2 adrenergic agonists in 27, racemic epinephrine in 8, mechanical ventilation in 12, ipratropium bromide in 5 and inhaled steroids in 13. After diagnosis, 24 patients received bronchodilator therapy with ipratropium bromide, 15 received racemic epinephrine and 22 received inhaled steroids. In 21, õ2 adrenergic agonists were discontinued. Thirteen patients required ventilation support and home oxygen. Twenty two patients showed a satisfactory clinical evolution and 6 patients died. Conclusions: The clinical presentation of tracheobronchomalacia is varied and diagnosis is done by flexible bronchoscopy. Treatment will depend on the severity of the disease, but õ2 adrenergic agonists should be excluded